High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases-Reference-Cited by-同舟云学术

High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases

Published:2020-10-23 Issue:11 Volume:84 Page:1957-1964
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hirano Mitsuhito¹,Kimura Koichi²³⁴,Ishigaki Tomohiro¹²,Nojima Masanori⁵,Daimon Masao⁴⁶,Morita Hiroyuki⁴,Takenaka Katsu⁶,Xu Boqing⁴,Sawada Naoko⁴,Hirokawa Megumi⁴,Komuro Issei⁴,Morisaki Takayuki³,Yotsuyanagi Hiroshi³,Kawamata Toyotaka¹,Yokoyama Kazuaki¹,Konuma Takaaki¹,Kato Seiko¹,Yasui Hiroshi¹,Nagamura-Inoue Tokiko¹²,Uchimaru Kaoru¹,Takahashi Satoshi¹,Imai Yoichi¹,Tojo Arinobu¹

Affiliation:

1. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo

2. Department of Laboratory Medicine, The Institute of Medical Science, The University of Tokyo

3. Department of General Medicine, The Institute of Medical Science, The University of Tokyo

4. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

5. Center for Translational Research, The Institute of Medical Science, The University of Tokyo

6. Department of Laboratory Medicine, The University of Tokyo Hospital, The University of Tokyo

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/84/11/84_CJ-20-0344/_pdf

Reference41 articles.

1. 1. Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768–2801.

2. 2. Okwuosa TM, Prabhu N, Patel H, Kuzel T, Venugopal P, Williams KA, et al. The cardiologist and the cancer patient challenges to cardio-oncology (or onco-cardiology) and call to action. J Am Coll Cardiol 2018; 72: 228–232.

3. 3. Jain D, Russell RR, Schwartz RG, Panjrath GS, Aronow W. Cardiac complications of cancer therapy: Pathophysiology, identification, prevention, treatment, and future directions. Curr Cardiol Rep 2017; 19: 36.

4. 4. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003; 97: 2869–2879.

5. 5. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672–1677.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question;Current Problems in Cardiology;2024-11

2. A unique combination of dilated cardiomyopathy and non- compaction cardiomyopathy in 75- year-old female with lupus erythematosus and hydroxychloroquine use;Journal of Cardiology & Current Research;2024-07-18

3. Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria;Diagnostics;2024-01-04

4. Uncompacted Myocardium: A Disease or a Phenotype?;ABC Heart Fail Cardiomyop;2023-09

5. Excessive Trabeculation of the Left Ventricle;JACC: Cardiovascular Imaging;2023-03